
Kardi Ai is a Czech company providing a medical-grade cardiac home monitoring service that combines a comfortable chest strap with an EKG sensor and a certified AI-driven mobile application. The service enables continuous heart rhythm monitoring anytime and anywhere, offering immediate alerts for irregularities and detailed reports for physicians. It targets prevention and early detection of serious cardiovascular diseases such as atrial fibrillation, which affects over half a million people in the Czech Republic. The solution is differentiated by its European medical certification, AI-powered EKG evaluation, and seamless connectivity with cardiologists, facilitating personalized treatment and lifestyle recommendations. Kardi Ai offers subscription plans and integrates with Polar H10 chest straps, serving individual users and healthcare providers, with a focus on improving diagnostic accuracy and patient outcomes.

Kardi Ai is a Czech company providing a medical-grade cardiac home monitoring service that combines a comfortable chest strap with an EKG sensor and a certified AI-driven mobile application. The service enables continuous heart rhythm monitoring anytime and anywhere, offering immediate alerts for irregularities and detailed reports for physicians. It targets prevention and early detection of serious cardiovascular diseases such as atrial fibrillation, which affects over half a million people in the Czech Republic. The solution is differentiated by its European medical certification, AI-powered EKG evaluation, and seamless connectivity with cardiologists, facilitating personalized treatment and lifestyle recommendations. Kardi Ai offers subscription plans and integrates with Polar H10 chest straps, serving individual users and healthcare providers, with a focus on improving diagnostic accuracy and patient outcomes.
Founded: 2022
Headquarters: Olomouc, Czechia
Product: Medical-grade ECG chest strap + certified AI mobile app for continuous heart-rhythm monitoring and clinician reports (EU MDR Class IIa)
Problem domain: Long-term heart rhythm monitoring and arrhythmia detection (including atrial fibrillation)
Recent funding: Seed €1.1M (Apr 28, 2025)
Notable investors: BrightCap Ventures, DEPO Ventures, Garage Angels, LUMUS Investment Collective
Long-term heart rhythm monitoring and remote arrhythmia detection (clinical decision support for cardiologists and monitoring for patients).
2022
Data and Analytics
€1.1M
Valuation shown €7.5M; investors listed for this round include DEPO Ventures, BrightCap Ventures, LUMUS Investment Collective, Garage Angels.
“Backed by early-stage VCs and angel groups including BrightCap Ventures, DEPO Ventures, Garage Angels, and LUMUS Investment Collective; early investor Vlastimil Hrabal later joined company leadership.”